UNDERGOING ENDOSCOPY

UNDERGOING ENDOSCOPY

Many patients undergoing endoscopy may be taking a medica tion that interferes with normal haemostasis, such as warfarin, heparin, direct oral anticoagulants, clopidogrel or aspirin. The key points to remember when managing anticoagulants in patients undergoing endoscopy are given in Summary box /uni00A0 9.4 . Summary box 9.4 Managing anticoagulants in patients undergoing endoscopy /uni25CF /uni25CF /uni25CF

It is important to recognise and understand: The risk of complications related to the underlying gastrointestinal disease from anticoagulant therapy The risk of haemorrhage related to an endoscopic procedure in the setting of anticoagulant therapy The risk of a thromboembolic/ischaemic event related to interruption of anticoagulant therapy

UNDERGOING ENDOSCOPY

Many patients undergoing endoscopy may be taking a medica tion that interferes with normal haemostasis, such as warfarin, heparin, direct oral anticoagulants, clopidogrel or aspirin. The key points to remember when managing anticoagulants in patients undergoing endoscopy are given in Summary box /uni00A0 9.4 . Summary box 9.4 Managing anticoagulants in patients undergoing endoscopy /uni25CF /uni25CF /uni25CF

It is important to recognise and understand: The risk of complications related to the underlying gastrointestinal disease from anticoagulant therapy The risk of haemorrhage related to an endoscopic procedure in the setting of anticoagulant therapy The risk of a thromboembolic/ischaemic event related to interruption of anticoagulant therapy

UNDERGOING ENDOSCOPY

Many patients undergoing endoscopy may be taking a medica tion that interferes with normal haemostasis, such as warfarin, heparin, direct oral anticoagulants, clopidogrel or aspirin. The key points to remember when managing anticoagulants in patients undergoing endoscopy are given in Summary box /uni00A0 9.4 . Summary box 9.4 Managing anticoagulants in patients undergoing endoscopy /uni25CF /uni25CF /uni25CF

It is important to recognise and understand: The risk of complications related to the underlying gastrointestinal disease from anticoagulant therapy The risk of haemorrhage related to an endoscopic procedure in the setting of anticoagulant therapy The risk of a thromboembolic/ischaemic event related to interruption of anticoagulant therapy